NEUmiRNA

Website

Developer of ribonucleic acid therapies intended to treat neurological disorders. The company provides anti-miRNA treatment for transformative disease modification for neurological conditions, enablin...

Healthcare
Copenhagen, Denmark
Founded 2020
11 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$22.1M
Last Round
N/A
Investors
+6 other investors
View all 6 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock NEUmiRNA's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required